Active ingredients
Pharmacological Group
Analogs
Complete analogs for the substance
- 1.2-2.1€ ≈100% Methylethylpiridinol
- 1.5-2.9€ ≈100% Виксипин
- 2.1-2.8€ ≈100% Emoxi-optic
- — ≈100% Methylethylpiridinol-Eskom
- — ≈100% Эмсибел
- 94% 1.9-2€ Emoxibel [Methylethylpiridinol and more 1Emoxipine]
- 94% — Emoxipin-AKOS [Methylethylpiridinol and more 1Emoxipine]
- 94% 2.4-3€ Emoxipine Neo [Methylethylpiridinol and more 1Emoxipine]
- 91% 2.4-3.7€ Emoxipine [Methylethylpiridinol and more 1Emoxipine]
- Show all
Analogs by action
Used in the treatment of
- T30 Burn and corrosion, body region unspecified
- S06 Intracranial injury
- L55 Sunburn
- I63 Cerebral infarction
- I61 Intracerebral haemorrhage
- I21.9 Acute myocardial infarction, unspecified
- I20.0 Unstable angina
- H59 Postprocedural disorders of eye and adnexa, not elsewhere classified
- H57.8 Other specified disorders of eye and adnexa
- H52.1 Myopia
- H36.0 Diabetic retinopathy (E10-E14+ with common fourth character .3)
- H34 Retinal vascular occlusions
- H26 Other cataract
- H16.8 Other keratitis
- H11.3 Conjunctival haemorrhage
- T88.8 Other specified complications of surgical and medical care, not elsewhere classified
- Z98.8 Other specified postsurgical states
- Z100* CHAPTER XXII Surgical practice
- H32.8 Other chorioretinal disorders in diseases classified elsewhere
- L57.0 Actinic keratosis
- I23.8 Other current complications following acute myocardial infarction
- H57.9 Disorder of eye and adnexa, unspecified
- H36.8 Other retinal disorders in diseases classified elsewhere
- H35 Other retinal disorders
- H31.4 Choroidal detachment